A recent study found that EHHADH depletion restrained proliferation, invasion, and migration of cancer cells, and facilitated the sensitivity of bladder cancer (BC) cells to cisplatin in vitro.17 The gene discussed is EHHADH; the disease is urinary bladder carcinoma.